Ranking of leading medical device stocks (detailed)
The in vitro diagnostic plate reported gains after hours, with Xinhua Medical (8.232) leading the way, followed by Anbipin, Goldmind, Kang for the century and others. The following is a ranking of leading medical device stocks, we take a look at it, hope to bring reference.
Ranking of Leading Medical Device Stocks
The report shows that in 2019, Myriad Healthcare realized operating income of 16.556 billion yuan, an increase of 20.38%% over the same period of the previous year; total profit of 5.368 billion yuan, an increase of 26.66% over the same period of the previous year; and net profit attributable to shareholders of listed companies of 4.681 billion yuan, an increase of 25.85% over the same period of the previous year; in 2019, the company intends to pay a cash dividend of 15 yuan per 10 shares to all shareholders (tax included).
Specifically, the top of the list in the medical device category is still the domestic mechanical enterprise "brother" Myriad Medical, Myriad Medical's business line is more comprehensive, covering the life of information and support, in vitro diagnosis, medical imaging in three major areas. Benefiting from the continuous release of policy dividends, sustained strong demand for medical devices, steady increase in the global market share of core products, and rapid expansion of domestic and international high-end customer base, Meizu Medical, China's largest and the world's leading medical device giants, once again relying on the eye-catching financial results for the vast majority of investors to inject a "strong heart.
The most promising biomedical leading stocks
1. Hengrui Medicine (600276), the first domestic innovative drugs. The main product lines are anti-tumor, anesthesia, contrast agents and so on. The company's return on net assets for many years to maintain more than 23%, net profit for many years to maintain a rate of growth of more than 20%. The company's R&D strength is very strong, the management team is relatively good, and the sales capacity is also very strong.
2. Aier Ophthalmology (300015), the first share of domestic ophthalmic hospital chain. Mainly to provide patients with a variety of ophthalmic diseases diagnosis, treatment and medical optometry and other ophthalmic medical services. The company's return on net assets for many years to maintain at about 20%, net profit for many years to maintain a rate of growth of more than 30%.
3. Myriad Medical (300760), the first domestic medical equipment. The main product lines are life and information support, in vitro diagnostics, medical imaging and so on. The company's return on net assets for many years to maintain more than 25%, net profit for many years to maintain a rate of growth of more than 25%.
What are the leading in vitro diagnostic stocks
1, Ribbon Instruments: leading stocks
2022 second quarter of Ribbon Instruments, Inc. main for patient monitoring, maternal and child health, ECG diagnostics, etc., revenues of 281 million yuan, 151 million yuan, 143 million yuan, or 33.38%%, 17.92%%, 16.95%%.
Libon Instruments released its Q3 2022 financial results, realizing operating income of 384 million yuan, up 2.08% year-on-year, with net income of 39.365 million yuan, -40.25% year-on-year; and earnings per share of 0.07 yuan.
2, UW Genetics: leading stocks
2022 second quarter of UW Genetics main business for precision medicine testing integrated solutions, infection prevention and control of basic research and clinical application services, reproductive health basic research and clinical application services, etc., revenues of 1.542 billion yuan, 573 million yuan, 566 million yuan, or 48.76% percent, 18.11% percent %%, 17.91%%.
The financial report shows that in the third quarter of 2022, the company's operating income of 1.353 billion yuan; net profit attributable to listed shareholders of 141 million yuan; fully diluted return on net assets of 1.44%; gross margin of 56.73%, earnings per share of 0.35 yuan.
3, Seri Medical: leading stocks
Second quarter of 2022 Seri Medical's main business for the IVD business, SPD business, simple sales, etc., revenue of 521 million yuan, 328 million yuan, 301 million yuan, accounting for 45.3%%, 28.51%%, 26.19%%.
Celi Medical released its Q3 2022 financial results, realizing operating income of 613 million yuan, up -2.48% year-on-year, and net income attributable to the mother of -6,694,500,000, -178.32% year-on-year; earnings per share was -0.03 yuan.
In-vitro diagnostic concept stocks which listed companies
1, Myriad Medical (300760): the company is mainly engaged in medical devices. February 10 after-hours news, Myriad Medical as of the close of trading at 3:00 p.m., the stock at 324.160 yuan, a decline of 0.87%, the stock price fell 1.5% in 7 days, the total market capitalization is 393.025 billion dollars.
2, Wantai biology (603392): the company is engaged in in vitro diagnostic reagents, instruments and vaccines, research and development, production and sales. after-hours update on February 10, Wantai biological 5-day share price rose 0.52%, as of the close of trading at 15:00 hours, the stock reported 129.330 yuan down 0.78%.
3, Fosun Pharmaceuticals (600196): the company is mainly engaged in drug manufacturing and research and development. As of 15:00, Fosun Pharmaceuticals rose 0.06%, the share price of 33.750 yuan, traded 15,040,600 shares, turnover amounted to 508 million yuan, the turnover rate of 0.71%, the latest A-share total market capitalization of 90.185 billion yuan, A-share market value of 71.473 billion yuan in circulation.
4, new industry (300832): the company is engaged in the research and development, production and sales of a series of automatic chemiluminescence immunoassay instruments and supporting reagents. 10 February after-hours news, the new industry opened at 61.59 yuan, as of the close of 15:00, the stock rose 0.52%, at 61.900 yuan, the total market capitalization of 48.661 billion yuan, the PE of 49.84.
5, Lepu medical shares traded at 508 million yuan, the latest A shares total market value of 90.185 billion yuan, A shares outstanding market value of 71.473 billion yuan. p>5, Lepu medical (300003): the company's main business for medical devices, pharmaceuticals, medical services and new medical business. after-hours news on February 10, Lepu medical 7 days the share price rose 3.43%, the latest rose 1%, at 24.170 yuan, the rate of change of 1.04%.
6, Shanghai Leslie (002252): the company is mainly engaged in the production and sale of blood products. February 10 news, Shanghai Leslie rose this year fell -8.48%, the latest at 6.250 yuan, up 1.13%, turnover 264 million yuan.
7, gold domain medicine (603882): the company is engaged in medical services. February 10 after-hours news, gold domain medicine opening quote 85.52 yuan, closed at 89.060 yuan, turnover 446 million yuan.
8, Renfu medicine (600079): the company's main business is medicine. February 10 after-hours news, Renfu medicine's latest offer of 25.380 yuan, down 0.82%, the stock price fell 3.62% in 3 days; this year's rise rose 1.1%, the price-earnings ratio of 29.17.
Medical testing stocks what leading stocks
1. Miles Medical: domestic medical device leader. Life information and support products, in vitro diagnostic products, medical imaging products.
2. Yuyue medical: respiratory oxygen, rehabilitation care, surgical instruments, high-value supplies, Chinese medicine diagnostic and therapeutic equipment, medicinal plasters and polymer hygiene excipients.
3. LOPE Medical: the leading cardiovascular medical equipment. Coronary artery dilation stent delivery system, endovascular elution stent system, PTCA balloon dilatation catheter, PTCA imaging guide wire.
4. Huahai Biotechnology: domestic regenerative medicine leader, the listed products are biological regenerative materials, including soft tissue repair series products oral repair membrane, biofilm, skin repair membrane has been widely used in stomatology, head and neck surgery, neurosurgery and other fields.
5. Chutian Science and Technology: medical equipment leader (automatic light checker, lyophilizer, drug dispensing system, etc., medical water equipment field).